Grantham, Mayo, Van Otterloo & Co (GMO)’s Freeport-McMoran FCX Stock Holding History
Bought
Maintained
Sold
Other funds holding FCX
VCM
VPM
Grantham, Mayo, Van Otterloo & Co (GMO)'s FCX Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Freeport-McMoran (FCX) stake by 27% in Q1 2026, selling an estimated $15.3M and leaving 701,125 shares worth $41.2M. The position accounts for 0.11% of the portfolio, ranked #87.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in FCX in Q2 2013 and has held it in 50 quarters since. The position peaked at $84.9M in Q1 2024. 1,847 funds tracked by Wall St. Rank hold FCX as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 701,125 shares of Freeport-McMoran worth $41.2M as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 253,400 Freeport-McMoran shares in Q1 2026, an estimated $15.3M.
- Freeport-McMoran made up 0.11% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #87 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Freeport-McMoran in Q2 2013 and has held it in 50 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Freeport-McMoran position peaked at $84.9M in Q1 2024.
- 1,847 funds tracked by Wall St. Rank held Freeport-McMoran as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.